Thursday, November 21, 2019 9:33:36 PM
I’m not so sure everything is a go with Allijon. Which may be the poker tell.
Still a ways off with the Car-t and Immunology for investors and trades. 5 years back when it popped it was bc of another Biotech was bought out traders thought cbmg may be next and Cbmg joined the Nasdaq.
I wonder if Cbmg could be the bridge for other Biotech JV’s in the U.S to get access to China? Sort of like the eastbridge model?
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Mawson Finland Provides Update on Exploration Activities at Rajapalot • MFL • Aug 21, 2024 9:06 AM
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM